chembl-mcp-server
Server Details
Link compounds to protein targets, rank bioactivity, and look up drug mechanisms and indications.
- Status
- Healthy
- Last Tested
- Transport
- Streamable HTTP
- URL
- Repository
- cyanheads/chembl-mcp-server
- GitHub Stars
- 1
- Server Listing
- @cyanheads/chembl-mcp-server
Available Tools
7 toolschembl_dataframe_describechembl-dataframe-describeARead-onlyIdempotentInspect
List the tables and columns staged on a canvas by chembl_get_bioactivities — inspect before calling chembl_dataframe_query to write correct SQL. Returns each table with its row count, kind (table | view), and column names + types. Requires CANVAS_PROVIDER_TYPE=duckdb.
| Name | Required | Description | Default |
|---|---|---|---|
| canvas_id | Yes | Canvas ID returned by chembl_get_bioactivities (spilled: true). |
Output Schema
| Name | Required | Description |
|---|---|---|
| error | No | Present when the call failed. Absent on success. |
| tables | No | Tables and views staged on the canvas. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=true, idempotentHint=true, and openWorldHint=false, covering the safety profile. The description adds value by specifying the return contents (row count, kind, column names/types) and the environment requirement, which the annotations do not convey.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is three short, tightly packed sentences. The primary purpose is front-loaded, and every sentence adds necessary information (what it lists, why to use it, return format, and a prerequisite). No filler or redundant phrases.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a simple tool with one parameter, an output schema, and annotations covering mutability, the description covers everything needed for correct invocation: its role relative to a sibling, the return content, and an environment requirement. Nothing essential is missing.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The schema covers the single parameter (canvas_id) with a description ('Canvas ID returned by chembl_get_bioactivities (spilled: true)'). The tool description does not add any new meaning beyond the schema, so a baseline score of 3 is appropriate.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description states a specific verb (List), a concrete resource (tables and columns staged on a canvas), and the source tool (chembl_get_bioactivities). It also names the sibling chembl_dataframe_query to distinguish this inspection tool from the query tool, making its purpose unmistakable.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
It gives explicit usage context: 'inspect before calling chembl_dataframe_query to write correct SQL' and states an environmental prerequisite (CANVAS_PROVIDER_TYPE=duckdb). This tells the agent precisely when to use the tool and what it enables.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_dataframe_querychembl-dataframe-queryARead-onlyIdempotentInspect
Run a read-only SQL SELECT over the bioactivity rows chembl_get_bioactivities spilled to a canvas — rank, group, dedupe, and aggregate across the FULL set, not the inline preview. Reference each staged table by the name chembl_get_bioactivities returned — bioactivities for its potency_ranked view, bioactivities_null_potency for null_potency; discover the staged tables and their columns with chembl_dataframe_describe. Compute honest aggregates here (e.g. SELECT molecule_chembl_id, MEDIAN(pchembl_value) AS med FROM bioactivities WHERE standard_type = 'IC50' GROUP BY 1 ORDER BY 2 DESC). Two independent bounds apply, each reported on its own field: truncated is true when the SQL result exceeded the canvas row cap, and rendered_rows says how many of the returned rows the markdown table holds once its character budget is reached (below row_count on a wide or long result). Page past either bound with SQL LIMIT/OFFSET — append e.g. LIMIT 500 OFFSET 500 and re-call; offsets reach rows beyond the canvas row cap. Requires CANVAS_PROVIDER_TYPE=duckdb.
| Name | Required | Description | Default |
|---|---|---|---|
| sql | Yes | A read-only SELECT against the staged tables. Reference tables by the names chembl_get_bioactivities returned. | |
| canvas_id | Yes | Canvas ID returned by chembl_get_bioactivities (spilled: true). |
Output Schema
| Name | Required | Description |
|---|---|---|
| rows | No | Result rows (capped at the canvas row limit). Each row is a column→value map. |
| error | No | Present when the call failed. Absent on success. |
| row_count | No | Number of rows materialized in this response. |
| truncated | No | True when the SQL result exceeded the canvas row cap and was truncated — the engine bounding the result set itself, not the rendering. Independent of rendered_rows; page past it with LIMIT/OFFSET. |
| rendered_rows | No | How many of those rows the markdown table in content[] holds. Below row_count when the rendered table reached its character budget — a rendering bound, INDEPENDENT of truncated: a response can be truncated:false and still render fewer rows than row_count. Re-run the same SQL with LIMIT/OFFSET to read the rows past it. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=true and idempotentHint=true, and the description reinforces this by calling it a 'read-only SQL SELECT'. Beyond that, it transparently discloses the two output bounds (truncated and rendered_rows), explains how they relate to row caps and character budgets, and states the dependency on CANVAS_PROVIDER_TYPE=duckdb. No contradiction with annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is long but information-dense, with each sentence serving a purpose. It is front-loaded with the core purpose, then details table naming, example SQL, bounds, and paging. While not terse, it is well-structured and avoids redundancy, making it efficient for an agent to parse.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given the tool's complexity (SQL query over staged tables with bounds and paging), the description covers all essential aspects: purpose, table naming conventions, an example query, behavior when limits are hit, how to page, and the runtime requirement. The presence of an output schema is handled by the description explaining the bound fields, so nothing critical is missing.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so the baseline is 3. The tool description adds value by giving an example SQL statement and clarifying that tables are referenced by names returned by chembl_get_bioactivities, which reinforces the schema. However, the parameter descriptions in the schema already convey most of the necessary meaning, so the incremental contribution is moderate.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description opens with a specific verb and resource ('Run a read-only SQL SELECT over the bioactivity rows...'), and immediately distinguishes itself from the sibling tool by stating 'across the FULL set, not the inline preview'. It also names the staged tables and views, making the tool's role unambiguous.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description explicitly tells the agent when to use this tool versus the preview provided by chembl_get_bioactivities, and points to chembl_dataframe_describe for discovering staged tables. It also gives concrete paging instructions ('append e.g. LIMIT 500 OFFSET 500 and re-call') and clarifies that aggregate computations should be done here.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_get_assaychembl-get-assayARead-onlyIdempotentInspect
Assay provenance behind a bioactivity row: description, type (binding / functional / ADMET / toxicity), the target it measures, organism, and ChEMBL's 1–9 confidence score (9 = direct assay on the protein target, lower = homologous or indirect). Supply assay_chembl_id from a chembl_get_bioactivities row. Call this to judge whether two measurements are comparable before ranking them together.
| Name | Required | Description | Default |
|---|---|---|---|
| assay_chembl_id | Yes | ChEMBL assay ID from a bioactivity row's assay_chembl_id, e.g. "CHEMBL674637". |
Output Schema
| Name | Required | Description |
|---|---|---|
| error | No | Present when the call failed. Absent on success. |
| organism | No | Assay organism. Null when unspecified. |
| assay_type | No | Assay type code: B=binding, F=functional, A=ADMET, T=toxicity, P=physicochemical, U=unclassified. Null when absent. |
| description | No | Assay description text. Null when absent. |
| assay_chembl_id | No | The ChEMBL assay ID queried. |
| confidence_score | No | ChEMBL confidence score, 1–9 (9 = direct single-protein assay; lower = homologous/indirect). Null when unscored. |
| target_chembl_id | No | ChEMBL target ID the assay measures — chain to chembl_search_targets/chembl_get_bioactivities. Null when unassigned. |
| assay_type_description | No | Human-readable assay type, e.g. "Binding". Null when absent. |
| confidence_description | No | Human-readable confidence description, e.g. "Direct single protein target assigned". Null when absent. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
The annotations already declare readOnlyHint, openWorldHint, and idempotentHint, which cover safety and idempotency. The description adds behavioral context beyond annotations by explaining the significance of the confidence score (9 = direct assay, lower = homologous/indirect) and how the result maps to data provenance. This helps the agent interpret the output correctly without contradicting annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is a single, well-organized sentence that front-loads the core purpose, then provides necessary details. It avoids fluff and each clause adds value. It could arguably be split into two sentences for readability, but it remains concise and structured.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given the tool has only one parameter, an output schema (which likely lists the returned fields), and the description covers the key semantic details (confidence interpretation, comparability use case), the definition is fully adequate. An agent can correctly invoke and interpret the tool without ambiguity.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The schema already documents the parameter with an example, but the description reinforces the source of the ID ('from a chembl_get_bioactivities row'), adding practical guidance on how to obtain the value. With 100% schema coverage, this additional contextualization elevates the score above the baseline.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description clearly states the tool's function: it provides assay provenance (description, type, target, organism, confidence score) for a bioactivity row. It uses a specific verb ('get') on a specific resource ('assay'), and distinguishes itself from siblings by referencing the source (bioactivity row) and the purpose (judging comparability).
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description explicitly instructs to supply assay_chembl_id from a chembl_get_bioactivities row and gives a concrete use case ('to judge whether two measurements are comparable before ranking them together'). While it does not explicitly state when not to use it, the guidance is clear and sufficient for an agent to decide. It does not name alternative tools, but the context implies this is the sole route for assay provenance.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_get_bioactivitieschembl-get-bioactivitiesARead-onlyIdempotentInspect
The flagship compound↔target bioactivity bridge: measurements for a molecule (target deconvolution / selectivity), a target (lead finding), or both together (how potently one compound hits one target). Supply at least one of molecule_chembl_id (from chembl_search_molecules) or target_chembl_id (from chembl_search_targets) — supplying both narrows to that compound–target pair, supplying neither is an error. Filter by standard_type (IC50/Ki/EC50/…), minimum potency pchembl_value_min, assay_type, and organism. Not every measurement has a derivable pchembl_value, so potency_view picks which side of that split you get: the default "potency_ranked" returns the measurements that have one, most potent first (ChEMBL sorts the rest first otherwise, which is why they are not merged), and "null_potency" returns exactly the measurements that have none. totalCount is the honest full match count across both views either way. Mixing measurement types (IC50 vs Ki) is a scientific error — set standard_type to compare like with like. A popular target carries tens of thousands of rows: results spill to a DataCanvas table (call chembl_dataframe_describe for its columns, then chembl_dataframe_query for honest aggregates across the staged set), while an inline preview answers the immediate question. Each view stages its own table (bioactivities / bioactivities_null_potency), so running both against one canvas_id lets a UNION ALL rebuild the full set. The staged table is capped at CHEMBL_MAX_SPILL_ROWS; when the cap is hit, truncated is true and the table is a bounded slice, not the complete view. The inline rows are always capped at limit, so compare that against totalCount before treating them as the whole answer. Spilling the rest requires CANVAS_PROVIDER_TYPE=duckdb; without it the inline preview is all there is.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | Maximum rows in the inline preview. Defaults to the server default (25). The full set still spills to the canvas. | |
| organism | No | Restrict to a target organism, e.g. "Homo sapiens" (case-insensitive exact match). | |
| canvas_id | No | Optional canvas ID from a prior call to reuse the same canvas. Each potency_view re-stages its own table, so a second query of the SAME view REPLACES (overwrites) its prior rows — it does not append — while the other view's table is left intact, which is what lets both coexist on one canvas. Omit to mint a fresh canvas. | |
| assay_type | No | Restrict to an assay type code: "B" (binding), "F" (functional), "A" (ADMET), "T" (toxicity). | |
| potency_view | No | Which side of the pchembl_value presence split to retrieve. "potency_ranked" (default) returns the measurements that have a derivable pchembl_value, most potent first. "null_potency" returns exactly the measurements that have none — the rows the ranked view excludes, otherwise unreachable. The two partition the match set and stage to separate canvas tables. | potency_ranked |
| standard_type | No | Restrict to one measurement type, e.g. "IC50", "Ki", "EC50". Set this to compare potencies validly. | |
| target_chembl_id | No | ChEMBL target ID (from chembl_search_targets), e.g. "CHEMBL203". Supply this, molecule_chembl_id, or both — both narrows to that compound–target pair. | |
| pchembl_value_min | No | Minimum pchembl_value (−log10 molar potency), e.g. 7 keeps sub-100 nM activities. Only valid on the potency_ranked view — the null_potency rows have no pchembl_value to compare against. | |
| molecule_chembl_id | No | ChEMBL molecule ID (from chembl_search_molecules), e.g. "CHEMBL941". Supply this, target_chembl_id, or both — both narrows to that compound–target pair. |
Output Schema
| Name | Required | Description |
|---|---|---|
| error | No | Present when the call failed. Absent on success. |
| notice | No | Guidance when no measurements matched, or how to SQL the spilled set. |
| spilled | No | True when the view exceeded the preview and was staged on the canvas. |
| canvas_id | No | Canvas ID holding the staged table — pass to chembl_dataframe_describe to list its columns, then to chembl_dataframe_query to run SQL over them. Null when canvas is disabled or nothing spilled. |
| truncated | No | True when the CHEMBL_MAX_SPILL_ROWS cap was hit before the upstream view was exhausted — the staged table is a bounded slice, NOT the complete view, so aggregates over it are a sample. Narrow the filters to bring the view under the cap. |
| activities | No | Bioactivity rows for the selected potency_view — the inline preview, or the full view when it fit without spilling. |
| table_name | No | Canvas table name holding the staged rowset, and the FROM target for chembl_dataframe_query SQL — "bioactivities" for potency_ranked, "bioactivities_null_potency" for null_potency. Null when not spilled. |
| totalCount | No | Total matching measurements upstream — the honest full count spanning BOTH potency views, before any preview cap. The staged/preview rows are the selected view of this. |
| potency_view | No | Which view these rows came from: "potency_ranked" = measurements with a derivable pchembl_value; "null_potency" = measurements with none. Re-call with the other value to reach the rest of totalCount. |
| appliedFilters | No | Filters as the server parsed them. |
| canvasDisabled | No | True when CANVAS_PROVIDER_TYPE is not duckdb, so large sets could not spill — the inline rows are a capped preview, not the full set. |
| staged_row_count | No | Rows actually registered on the canvas table. Null when nothing spilled. Below the view total when truncated is true. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations declare readOnlyHint, openWorldHint, and idempotentHint, but the description adds substantial behavioral context: the potency_view split with exact semantics of each side, the truncation cap with 'truncated' flag, the behavior of totalCount across views, and the canvas staging behavior (overwrite vs. coexist). It even explains why rows are not merged. This is precisely the kind of context that lets an agent predict side effects and data shape without risking a wrong call.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is long but every sentence carries information. It front-loads the core purpose, then systematically covers invocation, filtering, the two-view split, spill behavior, and tool integrations. There is no filler or repetition; each clause earns its place. The structured flow from 'what' to 'how' to 'edge cases' makes it easy for an agent to parse quickly.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given the tool's complexity (9 params, two views, spill logic, coordination with four sibling tools), the description is remarkably complete. It covers error conditions, partition semantics, truncation, canvas behavior, and cross-tool handoffs. The presence of an output schema covers return-value details, so the description appropriately focuses on invocation and behavioral nuances, leaving nothing ambiguous for a competent agent.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Though schema coverage is 100%, the description vastly enriches parameter meaning. It explains pchembl_value_min semantics, the scientific rationale for setting standard_type ('compare like with like'), the exact partition defined by potency_view, and the behavior of canvas_id across views. It goes beyond the schema's field descriptions to teach the agent how the parameters interact (e.g., pchembl_value_min only valid on potency_ranked). This is high-value added semantics.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description opens with a crisp purpose statement: 'flagship compound↔target bioactivity bridge' and immediately enumerates the three invocation modes (molecule-only, target-only, molecule+target) with their scientific use cases (deconvolution, lead finding, selectivity). This clearly distinguishes it from siblings like chembl_search_molecules or chembl_dataframe_query, and the verb 'get' plus resource 'bioactivities' makes the action unambiguous.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description provides explicit preconditions ('Supply at least one... supplying neither is an error'), explicit conditions for narrowing (both IDs), a warning against mixing measurement types, and clear direction on when to use companion tools (chembl_dataframe_describe/query for large result sets, and the condition for spilling needing duckdb). This goes far beyond generic guidance and gives an agent actionable decision rules.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_get_drug_infochembl-get-drug-infoARead-onlyIdempotentInspect
Pharmacology for a drug (molecule): mechanism(s) of action, the molecular target(s) it acts on, action type (inhibitor / agonist / …), first-approval year, and clinical indications with the max phase reached for each. Supply molecule_chembl_id (from chembl_search_molecules). Distinct from the openfda server's label/adverse-event view — this is the curated mechanism-and-indication record. A mechanism's target_chembl_id chains into chembl_get_bioactivities for compounds hitting the same target. Each list carries its own retrieval state: an empty mechanisms or indications array means the molecule has none recorded only when the matching mechanisms_status / indications_status is "complete" — "failed" means the upstream request was rejected and the array says nothing about the molecule, and "truncated" means the page cap bounded the list at fewer rows than the matching *_total_count.
| Name | Required | Description | Default |
|---|---|---|---|
| molecule_chembl_id | Yes | ChEMBL molecule ID (from chembl_search_molecules), e.g. "CHEMBL939" for gefitinib. |
Output Schema
| Name | Required | Description |
|---|---|---|
| error | No | Present when the call failed. Absent on success. |
| notice | No | Disclosure of anything the two lists do not say for themselves: a list whose upstream fetch failed (so its emptiness means nothing), a list the page cap bounded, or — only when both lists came back complete and empty — that the molecule may be a research compound rather than a drug. |
| max_phase | No | Max clinical phase across indications: 4 = marketed. Null when unknown. |
| pref_name | No | Preferred drug name, e.g. "GEFITINIB". Null when unnamed. |
| mechanisms | No | Mechanisms of action. Empty is authoritative only when mechanisms_status is "complete". |
| indications | No | Clinical indications. Empty is authoritative only when indications_status is "complete". |
| first_approval | No | Year of first approval, e.g. 2003. Null when unapproved or unknown. |
| mechanisms_status | No | Retrieval state of the mechanism list. "complete" = every row ChEMBL records is present, so an empty array is a fact about the molecule. "truncated" = the single-request page cap bounded the list, so the array is a prefix of mechanisms_total_count rows. "failed" = the upstream request was rejected, so the empty array is unknown data, NOT evidence that none exist — re-call chembl_get_drug_info to retry. |
| indications_status | No | Retrieval state of the indication list. "complete" = every row ChEMBL records is present, so an empty array is a fact about the molecule. "truncated" = the single-request page cap bounded the list, so the array is a prefix of indications_total_count rows. "failed" = the upstream request was rejected, so the empty array is unknown data, NOT evidence that none exist — re-call chembl_get_drug_info to retry. |
| molecule_chembl_id | No | The ChEMBL molecule ID queried. |
| mechanisms_total_count | No | Total mechanism rows ChEMBL holds for this molecule (upstream page_meta.total_count). Exceeds the returned array length exactly when the status is "truncated". Null when the fetch failed — the count is unknown, never 0. |
| indications_total_count | No | Total indication rows ChEMBL holds for this molecule (upstream page_meta.total_count). Exceeds the returned array length exactly when the status is "truncated". Null when the fetch failed — the count is unknown, never 0. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint, openWorldHint, and idempotentHint, but the description goes far beyond them by explaining the retrieval-state semantics: an empty mechanisms/indications array is meaningful only when the corresponding status is 'complete', while 'failed' and 'truncated' have distinct interpretations. This prevents the agent from misreading empty arrays as definitive absence of data—a critical behavioral nuance not captured by annotations. It also notes the chaining to bioactivities, adding functional context.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is dense yet efficient: it front-loads the core output, then covers input source, distinction from an alternative server, chaining to a sibling tool, and finally the crucial status semantics. Every sentence carries essential information—no filler. The structure is logical and well-organized, making it easy for an agent to parse despite its length.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Given the tool's complexity, the presence of an output schema, and the annotations, the description covers all critical aspects an agent needs: what data is returned, where the input comes from, how it differs from an alternative view, how to chain to related tools, and how to correctly interpret empty results via the status fields. It addresses a likely pitfall (interpreting empty arrays) and leaves no obvious gaps for correct invocation.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema coverage is 100% and the single parameter already has a detailed description ('ChEMBL molecule ID (from chembl_search_molecules), e.g. "CHEMBL939" for gefitinib.'). The tool description reiterates the source and adds an example, reinforcing the parameter's origin. Since the schema alone is nearly sufficient, the description adds marginal but useful value (source tool and concrete example), so a 4 is appropriate above the baseline of 3.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description opens with a clear verb and resource: 'Pharmacology for a drug (molecule)' followed by a specific list of what it returns (mechanisms, targets, action type, first-approval year, indications with max phase). It explicitly names the input ('Supply molecule_chembl_id') and distinguishes itself from the openfda server's label/adverse-event view, making it easy to differentiate from siblings like chembl_get_bioactivities or chembl_get_assay.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description provides strong contextual guidance: it states the input comes from chembl_search_molecules and differentiates this tool from the openfda server's view, indicating an alternative. It also chains to chembl_get_bioactivities via target_chembl_id, suggesting when to use that related tool. However, it does not explicitly state 'when not to use' this tool beyond the openfda distinction, and it lacks a crisp 'use this when you need curated pharmacology' statement, leaving some inference to the agent.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_search_moleculeschembl-search-moleculesARead-onlyIdempotentInspect
Discovery entry point for compounds. Find by name / ChEMBL ID / InChIKey with the default search_type=name (supply query), or run a structure search with search_type exact | similarity | substructure (supply structure as a SMILES). At least one of query or structure is required, and structure is required for the three structure modes. Returns ChEMBL ID, preferred name, canonical SMILES, formula, MW, AlogP, Lipinski violations, QED, and max clinical phase on every row; only search_type=similarity adds a Tanimoto similarity percent. Chain molecule_chembl_id into chembl_get_bioactivities or chembl_get_drug_info. A capped result carries nextCursor — pass it back as cursor with the same filters to read the next page.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | Maximum molecules to return. Defaults to the server default (25) when omitted. | |
| query | No | Search text for search_type=name — a drug name, ChEMBL ID, or InChIKey, e.g. "imatinib" or "CHEMBL25". | |
| cursor | No | Opaque continuation token from a previous call's nextCursor — resumes where that page ended. Omit for the first page. Re-send the same query/structure/filters that minted it (only limit may change; it sets this page's size); redeeming it against different filters walks a different result set. | |
| structure | No | SMILES string for structure search, e.g. "CC(=O)Oc1ccccc1C(=O)O". Required when search_type is exact/similarity/substructure. | |
| search_type | No | name = text lookup (query); exact = exact structure match; similarity = Tanimoto ≥ threshold; substructure = contains the structure. All structure modes need `structure`. | name |
| max_phase_min | No | For search_type=name, restrict to compounds at or above this max clinical phase (e.g. 4 for marketed drugs only). | |
| similarity_threshold | No | Minimum Tanimoto similarity percent for search_type=similarity (40–100; ChEMBL rejects below 40). Ignored for other modes. |
Output Schema
| Name | Required | Description |
|---|---|---|
| cap | No | The limit that was applied. |
| error | No | Present when the call failed. Absent on success. |
| shown | No | Number of molecules returned. |
| notice | No | Guidance when nothing matched — echoes the query and suggests how to broaden. |
| molecules | No | Matching compounds (up to the limit). |
| truncated | No | True when the result was capped at the limit. |
| nextCursor | No | Opaque token for the next page — pass it back as cursor with the same filters. Absent when this page is the last one. |
| totalCount | No | Total compounds matching before the limit was applied. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations (readOnlyHint=true, idempotentHint=true, openWorldHint=true) already carry the safety profile, so the description rightly focuses on behavior beyond that: the returned column set on every row, the Tanimoto-only-for-similarity caveat, pagination via nextCursor/cursor, and the cross-tool chaining. No contradiction with annotations — 'search', 'find', and 'read the next page' all align with readOnly. Could earn a 5 with explicit remarks on locking/limitations, but the pagination and return-format disclosure already exceed annotation coverage.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
Six dense sentences, logically ordered: purpose → modes → requirements → return fields → chaining → pagination. The 'Discovery entry point' framing is front-loaded. It is longer than average, but the tool has 7 parameters and 4 search modes, so the length is earned. Only minor tightening is possible (e.g., max_phase_min is absent from the description but well covered by the schema), so not a 5.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
Comprehensive for a complex tool: all search modes, input requirements, return columns, chaining targets, and pagination are covered. An output schema exists, so return-value explanation is a bonus rather than a need. Minor gaps — max_phase_min usage in the description and explicit filtering semantics — are fully handled by the parameter schema and output schema, so nothing an agent needs to call it correctly is missing.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so the baseline is 3 and the schema already documents every parameter well (ranges for similarity_threshold, cursor semantics, enum meanings for search_type). The description adds genuine cross-parameter combination logic — which fields are required in which mode, and that only limit may change when re-sending a cursor — which is valuable. But it does not add per-parameter meaning beyond the schema, keeping this at a solid 3.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
States a specific verb and resource ('Discovery entry point for compounds') plus the two distinct call shapes — name/ID/InChIKey lookup vs. structure search (exact | similarity | substructure). It differentiates from siblings by scope: chembl_search_targets searches targets, and the chain tools chembl_get_bioactivities / chembl_get_drug_info are downstream consumers, while this is the molecule search entry point. A tool like get_assay is clearly distinct. Nothing is ambiguous about what this tool does.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
Provides clear conditional context: default search_type=name needs query, structure modes need structure, and 'At least one of query or structure is required.' It also gives an actionable routing instruction — 'Chain molecule_chembl_id into chembl_get_bioactivities or chembl_get_drug_info.' It lacks explicit when-not-to-use or named exclusions against siblings, but the chaining direction and search-selector guidance make usage clear.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
chembl_search_targetschembl-search-targetsARead-onlyIdempotentInspect
Resolve a protein/gene/UniProt accession to the ChEMBL target ID that chembl_get_bioactivities needs for the target→leads workflow. Supply at least one of accession (UniProt, e.g. P00533), gene_symbol (e.g. EGFR), or query (free-text name); filter further by organism and target_type. Returns each target with its type, organism, and component UniProt accessions + gene symbols. A UniProt accession from the uniprot/protein server is the most precise input. A capped result carries nextCursor — pass it back as cursor with the same filters to read the next page.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | Maximum targets to return. Defaults to the server default (25) when omitted. | |
| query | No | Free-text name match against the target preferred name, e.g. "kinase" or "growth factor receptor". | |
| cursor | No | Opaque continuation token from a previous call's nextCursor — resumes where that page ended. Omit for the first page. Re-send the same accession/gene_symbol/query/filters that minted it (only limit may change; it sets this page's size); redeeming it against different filters walks a different result set. | |
| organism | No | Restrict to a source organism, e.g. "Homo sapiens" (case-insensitive exact match). | |
| accession | No | UniProt accession of a target component, e.g. "P00533". The most precise resolver — from the uniprot/protein server. | |
| gene_symbol | No | Gene symbol of a target component, e.g. "EGFR" (case-insensitive exact match). | |
| target_type | No | Restrict to a target class, e.g. "SINGLE PROTEIN" or "PROTEIN COMPLEX". |
Output Schema
| Name | Required | Description |
|---|---|---|
| cap | No | The limit that was applied. |
| error | No | Present when the call failed. Absent on success. |
| shown | No | Number of targets returned. |
| notice | No | Guidance when no target matched — echoes the filters and suggests how to broaden. |
| targets | No | Matching targets (up to the limit). |
| truncated | No | True when the result was capped at the limit. |
| nextCursor | No | Opaque token for the next page — pass it back as cursor with the same filters. Absent when this page is the last one. |
| totalCount | No | Total targets matching the filters before the limit was applied. |
TDQS
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=true, openWorldHint=true, and idempotentHint=true, covering safety and non-destructiveness. The description adds value by detailing the return payload (each target's type, organism, component UniProt accessions, and gene symbols) and the pagination behavior (nextCursor, pass back with same filters). This goes beyond annotations without contradicting them.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
The description is compact—three sentences—yet delivers the purpose, required inputs, optional filters, return structure, and pagination guidance. It is front-loaded with the core purpose and workflow link, and every sentence contributes. No fluff or repetition of schema details.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a 7-parameter search/resolution tool with no required parameters, the description is complete. It covers input options, precision ranking, filtering, return fields, and pagination. The existing output schema absorbs the need to describe return values in detail, and annotations already indicate safe read-only idempotent behavior. Nothing an agent needs to invoke it correctly is missing.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so each parameter is already documented. The description adds meaningful nuance beyond the schema: it flags accession as the most precise resolver (from the uniprot/protein server), clarifies that gene_symbol and organism are case-insensitive exact matches, and explains the cursor semantics in detail (only limit may change when redeeming). This enriches the schema's bare parameter definitions.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description explicitly states the verb 'Resolve' and the resource (protein/gene/UniProt to ChEMBL target ID), and ties it to a specific downstream workflow (needed by chembl_get_bioactivities). This clearly distinguishes it from sibling search tools like chembl_search_molecules or chembl_get_drug_info, which serve different resolution needs.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The description gives clear guidance on when to use this tool (to resolve an identifier before the bioactivities step) and specifies that at least one of accession/gene_symbol/query is required, with a hint that UniProt accession is the most precise. It also explains pagination via cursor. However, it does not explicitly name alternatives or state when NOT to use this tool in favor of a sibling, so it's slightly shy of a 5.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Frequently Asked Questions
Claiming proves that you control a remote MCP connector. It does not move, proxy, or interrupt the server.
Open the connector listing, choose Claim ownership, and sign in to Glama.
Complete one verification method:
GitHub identity — fastest for official registry listings. For a namespace such as
io.github.alice/server, link the matching GitHub user or an account that owns the GitHub organization, then choose Claim with GitHub.HTTP challenge — works when you can deploy a public file. Generate a token, publish the exact JSON Glama shows at
/.well-known/glama.jsonon the same origin as the connector, then choose Check HTTP challenge.DNS challenge — works when you control DNS but cannot change the server. Generate a token, create the exact TXT record Glama shows, wait for it to propagate, then choose Check DNS challenge.
After verification, Glama sends a confirmation email and gives you access to listing details, thumbnails, health checks, and analytics. Keep the HTTP file or DNS record in place: Glama periodically checks it and ownership remains verified while the token is discoverable.
The HTTP ownership file has this structure:
{
"$schema": "https://glama.ai/mcp/schemas/connector.json",
"claim": "glama_claim_..."
}Claim tokens are opaque, stable, and bound to the signed-in Glama account. They contain no email address or other personal information. If Glama can no longer discover a verified HTTP or DNS token, it starts a seven-day grace period before removing claim-based access. Restore the same token during that period to keep ownership verified. Never publish an email address, Glama session token, GitHub token, or connector credential as ownership proof.
If verification fails, confirm that you copied the current token exactly. The HTTP file must be public, return valid JSON with a successful HTTP response, and stay on the connector's origin. DNS changes may need more time to propagate. A claim cannot transfer to a different origin or hostname: if the connector target changes, Glama starts the grace period and the new target must be claimed separately after the previous claim is released.
For a connector linked to the official MCP Registry, registry updates continue to replace its name, description, and URL by default. After claiming, open Manage connector and enable Use Glama listing details as the source of truth if edits made on Glama should be preserved. Categories and thumbnails are always managed on Glama; registry linkage and technical connection settings continue to sync.
Control your server's listing on Glama, including description and metadata
Access analytics and receive server usage reports
Get monitoring and health status updates for your server
Feature your server to boost visibility and reach more users
To improve your MCP server's ranking:
Claim ownership of the server listing
Complete the server profile with an accurate description and thumbnail
Provide a test profile so Glama can connect to and evaluate the server
Keep tool definitions clear and complete to earn a high Tool Definition Quality Score (TDQS)
Route real usage through the Glama Gateway; more recorded successful server uses also improve the ranking
For users:
Full audit trail – every tool call is logged with inputs and outputs for compliance and debugging
Granular tool control – enable or disable individual tools per connector to limit what your AI agents can do
Centralized credential management – store and rotate API keys and OAuth tokens in one place
Change alerts – get notified when a connector changes its schema, adds or removes tools, or updates tool definitions, so nothing breaks silently
For server owners:
Proven adoption – public usage metrics on your listing show real-world traction and build trust with prospective users
Tool-level analytics – see which tools are being used most, helping you prioritize development and documentation
Direct user feedback – users can report issues and suggest improvements through the listing, giving you a channel you would not have otherwise
The connector status is unhealthy when Glama is unable to successfully connect to the server. This can happen for several reasons:
The server is experiencing an outage
The URL of the server is wrong
Credentials required to access the server are missing or invalid
If you are the owner of this MCP connector and would like to make modifications to the listing, including providing test credentials for accessing the server, please contact support@glama.ai.
Discussions
No comments yet. Be the first to start the discussion!
Related MCP Connectors
Biomedical data: compounds, drug info, and molecular targets
Search PubChem compounds, properties, safety data, bioactivity, and cross-references.
Query STRING interactions, enrichment, annotations, homology, and PPI networks.
Pharma Intel MCP — Compound tools that chain ClinicalTrials.gov,
Related MCP Servers
- AlicenseNot gradedqualityCmaintenanceEnables querying ChEMBL drug discovery database for molecules, targets, activities, and drug indications. Part of Pipeworx MCP gateway.15MIT
- AlicenseNot gradedqualityCmaintenanceProvides access to the NIH PubChem chemistry compound database, enabling queries for compound synonyms and other data through natural language.3MIT
- FlicenseBqualityFmaintenanceExtracts basic chemical information and drug data from the PubChem API. It enables users to retrieve molecular details such as SMILES, IUPAC names, molecular formulas, and synonyms for specific compounds.311
- AlicenseAqualityBmaintenancePre-clinical drug discovery intelligence MCP server providing 44 tools to query 800+ drug targets, 12K+ compounds, 46K+ papers, 18K+ clinical trials, and 16K+ patents.44Apache 2.0
Glama MCP Gateway
Add one secure layer between your agents and this server.
TDQS
Each tool targets a distinct resource or action: search for molecules and targets, fetch bioactivities, assays, and drug info, plus two dedicated dataframe helpers for analysis. There is no functional overlap—even the two dataframe tools are clearly separated as describe vs query. Agents can easily select the right tool for each step in a workflow.
All tools follow a consistent chembl_verb_noun pattern using snake_case (e.g., chembl_search_molecules, chembl_get_bioactivities, chembl_dataframe_query). The naming is uniform and predictable, with the verb always preceding the object. Minor deviation like dataframe_describe vs chembl_get_* still fits the same prefix and style, making it highly consistent.
With 7 tools, the server is well-scoped for its domain of compound-target bioactivity discovery and analysis. Each tool serves a clear purpose without redundancy, covering search, retrieval, provenance, pharmacology, and data manipulation. This is a textbook example of a focused toolset where every tool earns its place.
The tool surface covers the full read-only lifecycle: discover compounds and targets, fetch bioactivity measurements, drill into assay provenance, retrieve drug pharmacology, and perform aggregate analysis via SQL. All major workflows (target deconvolution, lead finding, selectivity assessment, and comparative ranking) are supported without dead ends. The only possible gap is write operations, but they are clearly out of scope for a reference database.